Sale!

LHCGR Gene Leydig cell hypoplasia type 1 Genetic Test

4,400 د.إ

-21%

The LHCGR Gene Leydig Cell Hypoplasia Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the LHCGR gene, which are responsible for Leydig cell hypoplasia type 1. Leydig cell hypoplasia is a rare disorder that affects sexual development due to the body’s inability to respond adequately to luteinizing hormone (LH), leading to insufficient testosterone production in males and affecting fertility in females. The test, priced at 4400 AED, is crucial for early diagnosis and management of the condition, offering insights into potential treatments and interventions to address the symptoms associated with this genetic disorder. DNA Labs UAE employs state-of-the-art technology to ensure accurate and reliable test results, providing essential genetic information for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LHCGR Gene Leydig cell hypoplasia type 1 Genetic Test

Cost: AED 4400.0

Test Details:

Leydig cell hypoplasia type 1 (LCH1) is a rare genetic disorder that affects the development and function of Leydig cells in the testes. This condition is caused by mutations in the LHCGR gene, which provides instructions for making the luteinizing hormone/choriogonadotropin receptor.

Components:

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Reproductive Disorders
  • Doctor: Gynecology
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for LHCGR Gene Leydig cell hypoplasia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LHCGR Gene Leydig cell hypoplasia type 1 NGS Genetic DNA Test gene LHCGR

Test Process:

In the context of Leydig cell hypoplasia type 1, an NGS genetic test can be used to identify mutations or variations in the LHCGR gene that may be responsible for the condition. The NGS genetic test for LCH1 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual undergoing testing. The DNA is then sequenced using NGS technology, which allows for the identification of specific variations or mutations in the LHCGR gene. The results of the test can help confirm a diagnosis of Leydig cell hypoplasia type 1 and provide valuable information for genetic counseling and management of the condition.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate guidance and support based on the test results.

Test Name LHCGR Gene Leydig cell hypoplasia type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Reproductive Disorders
Doctor Gynecology
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LHCGR Gene Leydig cell hypoplasia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LHCGR Gene Leydig cell hypoplasia type 1 NGS Genetic DNA Test gene LHCGR
Test Details

Leydig cell hypoplasia type 1 (LCH1) is a rare genetic disorder that affects the development and function of Leydig cells in the testes. This condition is caused by mutations in the LHCGR gene, which provides instructions for making the luteinizing hormone/choriogonadotropin receptor.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of Leydig cell hypoplasia type 1, an NGS genetic test can be used to identify mutations or variations in the LHCGR gene that may be responsible for the condition.

The NGS genetic test for LCH1 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual undergoing testing. The DNA is then sequenced using NGS technology, which allows for the identification of specific variations or mutations in the LHCGR gene. The results of the test can help confirm a diagnosis of Leydig cell hypoplasia type 1 and provide valuable information for genetic counseling and management of the condition.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate guidance and support based on the test results.